BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17344330)

  • 1. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.
    Fanoe S; Hvidt C; Ege P; Jensen GB
    Heart; 2007 Sep; 93(9):1051-5. PubMed ID: 17344330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc interval prolongation in patients on long-term methadone maintenance therapy.
    Maremmani I; Pacini M; Cesaroni C; Lovrecic M; Perugi G; Tagliamonte A
    Eur Addict Res; 2005; 11(1):44-9. PubMed ID: 15608471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
    Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
    Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.
    Chang KC; Huang CL; Liang HY; Chang SS; Wang YC; Liang WM; Lane HY; Chen CH; Stephen Huang SK
    J Cardiovasc Electrophysiol; 2012 May; 23(5):527-33. PubMed ID: 22136144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
    Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
    Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic opioids and QT prolongation.
    Krantz MJ; Mehler PS
    Arch Intern Med; 2003 Jul; 163(13):1615; author reply 1615. PubMed ID: 12860589
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
    J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsades de pointes with methadone.
    Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syncope of a drug addict - a special case.
    Chatterjee B; Bürgi U
    Clin Res Cardiol; 2006 Oct; 95(10):557-9. PubMed ID: 16865634
    [No Abstract]   [Full Text] [Related]  

  • 16. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.
    Athanasos P; Farquharson AL; Compton P; Psaltis P; Hay J
    J Addict Dis; 2008; 27(3):31-5. PubMed ID: 18956527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Review of cases of prolonged QTC and wave burst arrhythmia in patients treated with methadone].
    Laqueille X; Richa S; Kerbage H; Scart-Gres C; Berleur MP
    Encephale; 2012 Feb; 38(1):58-63. PubMed ID: 22381725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine-related torsade de pointes in a methadone maintenance patient.
    Krantz MJ; Rowan SB; Mehler PS
    J Addict Dis; 2005; 24(1):53-60. PubMed ID: 15774410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.